Výsledky vyhledávání - Mohammed Harb

  • Zobrazuji výsledky 1 - 7 z 7
Upřesnit hledání
  1. 1
    NUTM1 Gene Fusions Characterize a Subset of Undifferentiated Soft Tissue and Visceral Tumors

    NUTM1 Gene Fusions Characterize a Subset of Undifferentiated Soft Tissue and Visceral Tumors Autor Brendan C. Dickson, Yun‐Shao Sung, Marc K. Rosenblum, Victor E. Reuter, Mohammed Harb, Jay S. Wunder, David Swanson, Cristina R. Antonescu

    Vydáno 2018
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Synchronous clonally related anaplastic large cell lymphoma and malignant histiocytosis

    Synchronous clonally related anaplastic large cell lymphoma and malignant histiocytosis Autor Mohammed Harb, Tom Abrassart, Laurent Dewispeleare, Pierre Sidon, Naomi Dirckx, Anne‐Laure Trépant, Julie Castiaux, Pierre Heimann, Jean‐François Emile, Hussein Farhat

    Vydáno 2025
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    LBA65 The Canadian Cancer Trials Group PA.7 trial: Results of a randomized phase II study of gemcitabine (GEM) and nab-paclitaxel (Nab-P) vs GEM, nab-P, durvalumab (D) and tremelimumab (T) as first line therapy in metastatic pancreatic ductal adenocarcinoma (mPDAC)

    LBA65 The Canadian Cancer Trials Group PA.7 trial: Results of a randomized phase II study of gemcitabine (GEM) and nab-paclitaxel (Nab-P) vs GEM, nab-P, durvalumab (D) and tremelim... Autor D. J. Renouf, Jennifer J. Knox, Petr Kavan, Derek J. Jonker, Stephen Welch, Félix Couture, Frédéric Lemay, Mustapha Tehfé, Mohammed Harb, Nathalie Aucoin, Y-J. Ko, Patricia A. Tang, Ravi Ramjeesingh, Brandon M. Meyers, C. Kim, David F. Schaeffer, Jonathan M. Loree, Sharlene Gill, D. Tu, C. O'Callaghan

    Vydáno 2020
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Liver Metastases and Immune Checkpoint Inhibitor Efficacy in Patients With Refractory Metastatic Colorectal Cancer

    Liver Metastases and Immune Checkpoint Inhibitor Efficacy in Patients With Refractory Metastatic Colorectal Cancer Autor Eric X. Chen, Jonathan M. Loree, Emma Titmuss, Derek J. Jonker, Hagen F. Kennecke, Scott Berry, Félix Couture, Chaudharry E. Ahmad, John R. Goffin, Petr Kavan, Mohammed Harb, Bruce Colwell, Setareh Samimi, Benoît Samson, Tahir Abbas, Nathalie Aucoin, F. Aubin, Sheryl Koski, Alice C. Wei, Dongsheng Tu, Chris J. O’Callaghan

    Vydáno 2023
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer

    Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer Autor Eric X. Chen, Derek J. Jonker, Jonathan M. Loree, Hagen F. Kennecke, Scott Berry, Félix Couture, Chaudhary E. Ahmad, John R. Goffin, Petr Kavan, Mohammed Harb, Bruce Colwell, Setareh Samimi, Benoît Samson, Tahir Abbas, Nathalie Aucoin, F. Aubin, Sheryl Koski, Alice C. Wei, Nadine M Magoski, Dongsheng Tu, Chris J. O’Callaghan

    Vydáno 2020
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma

    The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma Autor Daniel J. Renouf, Jonathan M. Loree, Jennifer J. Knox, James T. Topham, Petr Kavan, Derek J. Jonker, Stephen Welch, Félix Couture, Frédéric Lemay, Mustapha Tehfé, Mohammed Harb, Nathalie Aucoin, Yoo‐Joung Ko, Patricia A. Tang, Ravi Ramjeesingh, Brandon M. Meyers, Christina Kim, Pan Du, Shidong Jia, David F. Schaeffer, Sharlene Gill, Dongsheng Tu, Chris J. O’Callaghan

    Vydáno 2022
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

    Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer Autor Thierry Conroy, Florence Castan, Anthony Lopez, Anthony Turpin, Méher Ben Abdelghani, Alice C. Wei, Emmanuel Mitry, James Biagi, Ludovic Evesque, Pascal Artru, Thierry Lecomte, Eric Assénat, Lucile Bauguion, Marc Ychou, Olivier Bouché, Laure Monard, Aurélien Lambert, Pascal Hammel, Éric François, Jean‐François Ramée, Hélène Castanie, Marc Pracht, François Ghiringhelli, Emmanuel Maillard, Caroline Couffon, Julien Volet, Vincent Bourgeois, Marion Chauvenet, Jean‐Frédéric Blanc, Denis Péré-Vergé, Christelle de la Fouchardière, Antoine Adenis, Farid El Hajbi, Jaafar Bennouna, Patrick Texereau, Roger Faroux, Laurent Miglianico, Christian Platini, Jean-Louis Legoux, François‐Xavier Caroli‐Bosc, Karine Bouhier‐Leporrier, Alice Gagnaire, Victoire Granger, Valérie Lebrun-Ly, Rosine Guimbaud, Yann Touchefeu, Mohamed Gasmi, Frédéric Di Fiore, Jean François Seitz, Pierre-Luc Etienne, Catherine Poisson, Yves Rinaldi, Nabil Baba-Hamed, Jean‐Baptiste Bachet, Thomas Aparicio, Laurence Choné, Marielle Guillet, Julien Forestier, Éric Terrebonne, Mohamed Hebbar, Gilles Breysacher, Thierry André, Faiza Khemissa-Akouz, Vincent Hautefeuille, Véronique Guerin‐Meyer, Johannes Hartwig, Y. Bécouarn, David Malka, Christophe Louvet, Jean‐Luc Raoul, L. Cany, Beata Juzina, C. Jouffroy, Sophie Gourgou, Mohammad Rassouli, Haji Chalchal, Daniel J. Renouf, Ralph Wong, Frédéric Lemay, F. Aubin, Félix Couture, Elaine Mc Whirter, Stephen Welch, Petr Kavan, B. Findlay, C. Cripps, P. Andrés-Cano, Shahid Ahmed, Mohammed Harb, Bryn Pressnail, Scott Dowden, Chris J. O’Callaghan

    Vydáno 2022
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: